Enter assignee name

Forward Citations = 15

Loading Chart...

11 inventors (with patents filed for the assignee):

Fang-Yu Liu (9 out of 11 patents)

K C Sung (5 out of 7 patents)

Chin-Yao Yang (5 out of 7 patents)

4. Chi-Cheng Lin (5 out of 10 patents)

5. Yi-Hsin Lin (5 out of 6 patents)

6. Li Qiao (5 out of 6 patents)

7. Kc Sung (4 out of 4 patents)

8. Yu Zhang (4 out of 37 patents)

9. Shang Wei Qin (4 out of 4 patents)

10. George Kraft (4 out of 4 patents)

11. John Duan (4 out of 4 patents)

9 patents: Sort by Forward Citations

1. 12522567 - Cabozantinib compositions and methods of use (2026-01-13),

2. 12516026 - Cabozantinib compositions and methods of use (2026-01-06),

3. 12516025 - Cabozantinib compositions and methods of use (2026-01-06),

4. 12415784 - Cabozantinib compositions and methods of use (2025-09-16),

5. 12064430 - Kinase inhibitor salts and compositions thereof (2024-08-20),

6. 12064428 - Kinase inhibitor salts and compositions thereof (2024-08-20),

7. 11052088 - Kinase inhibitor salts, and compositions thereof (2021-07-06),

8. 11007195 - Kinase inhibitor salts, and compositions thereof (2021-05-18),

9. 10940149 - Kinase inhibitor salts and compositions thereof (2021-03-09),

Handa Oncology, LLC is a leading biopharmaceutical company focused on developing innovative cancer therapies. With a deep commitment to advancing oncology research, Handa Oncology is dedicated to improving outcomes for cancer patients worldwide. The company's pipeline includes novel targeted therapies and immunotherapies for a range of cancer types. Handa Oncology's mission is to revolutionize cancer treatment through scientific innovation and patient-centered care.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 20 2026

9 Patents

#524 in San Jose, CA

#7,533 in California

#31,732 in US

San Jose, CA, United States of America

Handa Oncology, LLC